Kristen Wolff

Kristin Viswanathan Wolff is the VP of Market Access for bluebird bio. She joined the company in 2017 as the Director, Global Government Affairs and Policy. bluebird is a clinical stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing cell and gene therapies for severe genetic diseases and cancer. In her current role, Kristin is responsible for developing and implementing multi-year regulatory and reimbursement policy strategies at the global and market-specific levels (U.S. and E.U.) that enable patient access to cell and gene therapies. She is a subject matter expert in U.S. market access, especially driving timely, high-quality access for rare disease therapies across payer segments. Prior to her current role, Kristin served in multiple roles at bluebird bio, including as VP of Payer Engagement and Access and VP of Global Policy Strategy and US Government Payer. In these roles she has worked to shape the regulatory landscape in target markets to enable patient access to bluebird gene therapies once approved and to better ensure that reimbursement systems take into account the value these therapies can provide to patients and healthcare systems over the short and long term. Prior to joining bluebird, Kristin held the role of Director, Reimbursement & Health Policy at the Biotechnology Innovation Organization (BIO), a trade association representing R&D-intensive, innovative biopharmaceutical companies, headquartered in Washington, D.C. At BIO, her portfolio included traditional coding, coverage, and reimbursement policy under Medicare and Medicaid, as well as issues related to the implementation of the Affordable Care Act (ACA) and the Medicare Access and CHIP Reauthorization Act (MACRA). At BIO, Kristin led workstreams specifically related to value-based payment arrangements and value assessment frameworks in the U.S. Kristin came to BIO in 2012 from the National Academy of Medicine (NAM) (formerly the Institute of Medicine) having supported expert publications authored on behalf of the NAM Forums on Neuroscience and Nervous System Disorders, and Medical and Public Health Preparedness for Catastrophic Events. Kristin holds a B.A. in Neuroscience from the Johns Hopkins University and an MPH from Dartmouth College.